In the next section we will describe how the use of APP translation activators such as the m1 muscarinic acid AF10B are attractive candidates in circumstances while such agents are also co-activators of alpha-secretases, thus eliminating the risk of amyloidosis when pharmacologically increasing the intracellular presence of APP template. Here, APP is linked to amyloidosis.